Table 1.
Characteristics of the studies included in this scoping review.
| Author(s), year | Country | Publication type | JCR 2021 | Citescore | Study design | Setting | Study population |
|---|---|---|---|---|---|---|---|
| Danziger, Piscitelli, 199321 | USA | Research article | 3.204 | 3.8 | Analytical cross-sectional | Clinic | Patients in use of dapsone |
| de Vasconcelos et al., 201722 | Brazil | Research article | NA | 0.6 | Descriptive cross-sectional | Clinic | Patients in use of thalidomide |
| Fischer, West, and Worobec, 198623 | USA | Research article | 0.222 | NA | Analytical cross-sectional | Clinic | Patients in use of dapsone |
| Guerra, Pontes e Randau 202224 | Brazil | Research article | NA | NA | Descriptive cross-sectional | Clinic | Any patients |
| Kannan et al., 200925 | India | Research article | 0.664 | 1.1 | Descriptive cross-sectional | Ambulatory | Patients in use of dapsone |
| Ramos et al., 202226 | Brazil | Research article | NA | NA | Descriptive cross-sectional | Ambulatory | Any patients |
| Sales et al., 202027 | Brazil | Research article | NA | NA | Descriptive cross-sectional | Public community pharmacy | Patients in use of thalidomide |
| Santos, 201328 | Brazil | End-of-graduate course treatise | NA | NA | Descriptive cross-sectional | Primary care | Any patients |
Abbreviations: JCR (Journal Citation Reports), NA (not applicable), USA (United States of America).